Ablation of difficult right-sided accessory pathways aided by mapping of tricuspid annular activation using a Halo catheter : Halo-mapping of right sided accessory pathways.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 17115266)

Published in J Interv Card Electrophysiol on November 18, 2006

Authors

Tom Wong1, Wajid Hussain, Vias Markides, Diana A Gorog, Ian Wright, Nicholas S Peters, D Wyn Davies

Author Affiliations

1: Waller Cardiology Department, St. Mary's Hospital and Imperial College, Praed Street, Paddington, London W2 1NY, UK. tom.wong@imperial.ac.uk

Articles cited by this

Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med (1991) 4.83

A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol (1996) 4.53

Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation (1999) 3.67

Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography. Circulation (1995) 2.14

Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation (2003) 1.93

Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients. J Cardiovasc Electrophysiol (1993) 1.87

Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation (1994) 1.81

Improved localization of right-sided accessory pathways with microcatheter-assisted right coronary artery mapping in children. J Cardiovasc Electrophysiol (2004) 1.60

Activation and entrainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter. Circulation (1996) 1.56

Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein's anomaly. Circulation (1996) 1.44

Ventricular preexcitation. A proposed nomenclature for its substrates. Eur J Cardiol (1975) 1.39

New algorithm for the localization of accessory atrioventricular connections using a baseline electrocardiogram. J Am Coll Cardiol (1994) 1.37

Recurrence of conduction in accessory atrioventricular connections after initially successful radiofrequency catheter ablation. J Am Coll Cardiol (1992) 1.19

Exclusion of fluoroscopy during ablation treatment of right accessory pathway in children. J Cardiovasc Electrophysiol (2002) 1.10

Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm. Am J Cardiol (1994) 1.09

Reasons for prolonged or failed attempts at radiofrequency catheter ablation of accessory pathways. J Am Coll Cardiol (1996) 1.07

Radiofrequency ablation of a right atrial appendage-ventricular accessory pathway by transcutaneous epicardial instrumentation. J Cardiovasc Electrophysiol (2000) 1.02

Typical atrial flutter ablation: conduction across the posterior region of the inferior vena cava orifice may mimic unidirectional isthmus block. J Cardiovasc Electrophysiol (2000) 1.01

Catheter ablation of accessory atrioventricular pathways in young patients: use of long vascular sheaths, the transseptal approach and a retrograde left posterior parallel approach. J Am Coll Cardiol (1993) 0.97

Anatomy of the atrioventricular junctions with regard to ventricular preexcitation. Pacing Clin Electrophysiol (1997) 0.95

Recurrence of conduction following radiofrequency catheter ablation procedures: relationship to ablation target and electrode temperature. The Atakr Multicenter Investigators Group. J Cardiovasc Electrophysiol (1996) 0.89

An accurate stepwise electrocardiographic algorithm for localization of accessory pathways in patients with Wolff-Parkinson-White syndrome from a comprehensive analysis of delta waves and R/S ratio during sinus rhythm. Am J Cardiol (1995) 0.87

Transvenous catheter ablation of a posteroseptal accessory pathway in a patient with the Wolff-Parkinson-White syndrome. N Engl J Med (1984) 0.87

Electrophysiologic characteristics and radiofrequency catheter ablation in patients with clockwise atrial flutter. J Cardiovasc Electrophysiol (1997) 0.86

Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation. Circulation (2000) 0.86

Radiofrequency catheter ablation of accessory pathway-mediated tachycardia is a safe and effective long-term therapy. Arch Med Res (2003) 0.85

Multiple accessory pathways in pediatric patients with Wolff-Parkinson-White syndrome. Am J Cardiol (2003) 0.81

Radiofrequency catheter ablation of accessory atrioventricular pathways: primary failure and recurrence of conduction. Heart (1997) 0.80

Recurrence rate after accessory pathway ablation. Br Heart J (1994) 0.77

Simultaneous mapping of the tricuspid and mitral valve annuli at electrophysiological study. Br Heart J (1995) 0.77

Successful radiofrequency current catheter ablation of accessory atrioventricular pathway in Ebstein's anomaly using electroanatomic mapping. Pacing Clin Electrophysiol (2002) 0.77

Electrocardiographic and electrophysiologic characteristics of anterior, midseptal and right anterior free wall accessory pathways. J Am Coll Cardiol (1992) 0.77

Articles by these authors

Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm (2012) 8.03

HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm (2007) 7.20

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace (2012) 5.84

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46

HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace (2007) 2.87

Atrial fibrillation: strategies to control, combat, and cure. Lancet (2002) 2.61

Fundamental trade-offs generating the worldwide leaf economics spectrum. Ecology (2006) 2.49

Heterogeneous gap junction remodeling in reentrant circuits in the epicardial border zone of the healing canine infarct. Cardiovasc Res (2006) 2.08

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08

Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts. Circ Res (2003) 1.95

Wolff-Parkinson-White ablation after a prior failure: a 7-year multicentre experience. Europace (2010) 1.88

Comet 81P/Wild 2 under a microscope. Science (2006) 1.83

Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping. Heart Rhythm (2007) 1.76

Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv (2010) 1.74

A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol (2013) 1.73

Detection of the diastolic pathway, circuit morphology, and inducibility of human postinfarction ventricular tachycardia from mapping in sinus rhythm. Heart Rhythm (2008) 1.63

Characterization of the left atrial neural network and its impact on autonomic modification procedures. Circ Arrhythm Electrophysiol (2013) 1.63

Characterization of left atrial activation in the intact human heart. Circulation (2003) 1.61

Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. J Am Coll Cardiol (2010) 1.56

Long-term results after ablation of infarct-related ventricular tachycardia. Heart Rhythm (2005) 1.55

Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f). FASEB J (2008) 1.54

Review article: Non-invasive assessment of cardiac output with portable continuous-wave Doppler ultrasound. Emerg Med Australas (2008) 1.53

The atrioventricular delay of cardiac resynchronization can be optimized hemodynamically during exercise and predicted from resting measurements. Heart Rhythm (2007) 1.52

Catheter inversion: a technique to complete isthmus ablation and cure atrial flutter. Pacing Clin Electrophysiol (2004) 1.47

Contact force sensing technology identifies sites of inadequate contact and reduces acute pulmonary vein reconnection: a prospective case control study. Int J Cardiol (2012) 1.40

SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ Arrhythm Electrophysiol (2011) 1.40

Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res (2003) 1.31

Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation. Heart (2010) 1.29

Progress in carbon dioxide separation and capture: a review. J Environ Sci (China) (2008) 1.24

A probabilistic patch-based label fusion model for multi-atlas segmentation with registration refinement: application to cardiac MR images. IEEE Trans Med Imaging (2013) 1.23

Plasticity of surface structures and β(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circ Heart Fail (2012) 1.23

Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res (2013) 1.20

Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm (2006) 1.20

Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J (2012) 1.19

The GuideLiner "child" catheter for percutaneous coronary intervention - early clinical experience. J Invasive Cardiol (2010) 1.19

Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J Am Coll Cardiol (2009) 1.18

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler (2013) 1.16

Biventricular pacing exclusively via a persistent left-sided superior vena cava: case report. Pacing Clin Electrophysiol (2003) 1.15

Determination of optimal atrioventricular delay for cardiac resynchronization therapy using acute non-invasive blood pressure. Europace (2006) 1.15

Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay. Heart (2006) 1.14

Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.12

Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an I Ks transgenic mouse. J Physiol (2007) 1.10

Relative expression of immunolocalized connexins 40 and 43 correlates with human atrial conduction properties. J Am Coll Cardiol (2002) 1.09

Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know? Pacing Clin Electrophysiol (2011) 1.08

Connexin40 imparts conduction heterogeneity to atrial tissue. Circ Res (2008) 1.06

Relationship between gap-junctional conductance and conduction velocity in mammalian myocardium. Circ Arrhythm Electrophysiol (2013) 1.03

Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches. J Cardiovasc Transl Res (2012) 1.00

Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev (2010) 0.99

International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (2003) 0.98

Spatiotemporal behavior of high dominant frequency during paroxysmal and persistent atrial fibrillation in the human left atrium. Circ Arrhythm Electrophysiol (2012) 0.98

Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon. Am J Physiol Heart Circ Physiol (2006) 0.97

Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience. J Cardiovasc Electrophysiol (2013) 0.97

Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements. Nat Rev Cardiol (2009) 0.97

Relationship between contact force sensing technology and medium-term outcome of atrial fibrillation ablation: a multicenter study of 600 patients. J Cardiovasc Electrophysiol (2015) 0.97

Age-related changes in human left and right atrial conduction. J Cardiovasc Electrophysiol (2006) 0.96

Use of thrombectomy devices in primary percutaneous coronary intervention: a systematic review and meta-analysis. Int J Cardiol (2011) 0.96

Intrinsic cardiac autonomic stimulation induces pulmonary vein ectopy and triggers atrial fibrillation in humans. J Cardiovasc Electrophysiol (2011) 0.96

Robotic assistance and general anaesthesia improve catheter stability and increase signal attenuation during atrial fibrillation ablation. Europace (2012) 0.95

Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants. N Engl J Med (2016) 0.95

Intra-coronary guidewire mapping-a novel technique to guide ablation of human ventricular tachycardia. J Interv Card Electrophysiol (2007) 0.95

A fortuitous syncope. The pitfalls of integrated bipolar defibrillator leads. Indian Pacing Electrophysiol J (2008) 0.94

Relationship between connexins and atrial activation during human atrial fibrillation. J Cardiovasc Electrophysiol (2004) 0.94

Percutaneous pulmonary vein cryoablation to treat atrial fibrillation. J Interv Card Electrophysiol (2004) 0.93

Maximizing efficiency of alternation algorithms for hemodynamic optimization of the AV delay of cardiac resynchronization therapy. Pacing Clin Electrophysiol (2010) 0.92

The effects of carbenoxolone on human myocardial conduction: a tool to investigate the role of gap junctional uncoupling in human arrhythmogenesis. J Am Coll Cardiol (2006) 0.92

Characterization of the electroanatomical substrate in human atrial fibrillation: the relationship between changes in atrial volume, refractoriness, wavefront propagation velocities, and AF burden. J Cardiovasc Electrophysiol (2007) 0.92

Improvement in coronary blood flow velocity with acute biventricular pacing is predominantly due to an increase in a diastolic backward-travelling decompression (suction) wave. Circulation (2012) 0.91

Localization of the isthmus in reentrant circuits by analysis of electrograms derived from clinical noncontact mapping during sinus rhythm and ventricular tachycardia. J Cardiovasc Electrophysiol (2004) 0.91